• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析日本 2015-2018 年多药处方数量的区域差异及其预测因素。

Analysis of the regional difference in the number of multi-drug prescriptions and its predictors in Japan, 2015-2018.

机构信息

Medical Information Center, Kyushu University Hospital, Maidashi 3-1-1 Higashi-ku, Fukuoka City, Fukuoka Prefecture, 812-8582, Japan.

Department of Pharmaceutical Sciences, International University of Health and Welfare, Fukuoka, Japan.

出版信息

BMC Res Notes. 2021 Sep 20;14(1):367. doi: 10.1186/s13104-021-05787-2.

DOI:10.1186/s13104-021-05787-2
PMID:34544503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8454144/
Abstract

OBJECTIVE

Polypharmacy and multi-drug prescription are major public health problems in Japan, but only a few studies have investigated the regional differences. By revealing regional differences in the multi-drug prescriptions, we can infer regions with high rates of multimorbidity or inappropriate prescribing. This study revealed regional differences in multi-drug prescriptions (the number of simultaneous prescriptions of seven or more internal medicines) and investigated the factors affecting the difference using the National Database of Health Insurance Claims and Specific Health Checkups of Japan data.

RESULTS

The standardized claim ratio (SCR) of the number of multi-drug prescriptions, which corrected the difference in sex and age distribution of prefectures, varied depending on prefectures. A panel data analysis investigating the association between the SCR and explanatory variables (Medical institutions, socioeconomic factors, and physical characteristics of people in prefectures) revealed that the number of public assistance recipients per 1,000 persons was positively and significantly associated with the SCR (Standardized partial regression coefficient = 0.244, p-value = 0.038). In conclusion, regional differences in the number of the multi-drug prescriptions were revealed in Japan, suggesting that public assistance recipients tend to experience multi-drug prescriptions.

摘要

目的

药物滥用和多药处方是日本的主要公共卫生问题,但只有少数研究调查了区域差异。通过揭示多药处方的区域差异,我们可以推断出多发病或不当处方率较高的地区。本研究利用日本国民健康保险索赔和特定健康检查全国数据库揭示了多药处方(同时开具七种或更多种内科药物的处方数)的区域差异,并调查了使用这些数据影响差异的因素。

结果

标准化索赔率(SCR)校正了各县市性别和年龄分布差异的多药处方数量存在差异。对 SCR 与解释变量(医疗机构、社会经济因素和各县市人口的身体特征)之间的关联进行的面板数据分析表明,每 1000 人中接受公共援助的人数与 SCR 呈正相关且显著相关(标准化部分回归系数=0.244,p 值=0.038)。总之,日本揭示了多药处方数量的区域差异,表明接受公共援助的人往往会经历多药处方。

相似文献

1
Analysis of the regional difference in the number of multi-drug prescriptions and its predictors in Japan, 2015-2018.分析日本 2015-2018 年多药处方数量的区域差异及其预测因素。
BMC Res Notes. 2021 Sep 20;14(1):367. doi: 10.1186/s13104-021-05787-2.
2
Analysis of regional differences in the amount of hypnotic and anxiolytic prescriptions in Japan using nationwide claims data.利用全国范围内的理赔数据分析日本催眠和抗焦虑药物处方数量的地区差异。
BMC Psychiatry. 2022 Jan 19;22(1):44. doi: 10.1186/s12888-021-03657-6.
3
Regional difference in multi-psychotropic drug prescription in Japan and its associated factors: an ecological study using national health insurance claims data.日本多种精神药物处方的地区差异及其相关因素:一项使用国民健康保险理赔数据的生态学研究
Res Health Serv Reg. 2023 Jan 5;2(1):1. doi: 10.1007/s43999-022-00018-y.
4
Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015.2012-2015 年利用日本国民健康保险索赔数据库估计的髋部骨折发病率。
Osteoporos Int. 2019 May;30(5):975-983. doi: 10.1007/s00198-019-04844-8. Epub 2019 Jan 16.
5
Regional variance in patterns of prescriptions for chronic kidney disease in Japan.日本慢性肾脏病处方模式的地域差异。
Clin Exp Nephrol. 2019 Jun;23(6):859-864. doi: 10.1007/s10157-019-01720-x. Epub 2019 Mar 1.
6
Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.根据患有多种合并症和多种药物治疗的患者的明确和隐含标准,潜在不适当的处方。MULTIPAP:一项横断面研究。
PLoS One. 2020 Aug 12;15(8):e0237186. doi: 10.1371/journal.pone.0237186. eCollection 2020.
7
Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.日本实施多种药物治疗减少政策后精神药物处方的变化:基于大规模索赔数据库的研究。
Clin Drug Investig. 2019 Nov;39(11):1077-1092. doi: 10.1007/s40261-019-00838-w.
8
Potentially inappropriate drug prescribing in elderly hospitalized patients: an analysis and comparison of explicit criteria.老年住院患者潜在不适当用药情况:明确标准的分析与比较
Int J Clin Pharm. 2016 Apr;38(2):462-8. doi: 10.1007/s11096-016-0284-7. Epub 2016 Mar 16.
9
Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data.德国老年人中按照 PRISCUS 清单指征开具潜在不适当药物(PIM)的情况。一项基于地区索赔数据的分析。
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):719-27. doi: 10.1002/pds.3429. Epub 2013 Apr 12.
10
Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.慢性病老年患者的多病共存模式、潜在不适当处方和药物不良反应:多中心前瞻性队列研究 MoPIM 的方案。
BMJ Open. 2020 Jan 26;10(1):e033322. doi: 10.1136/bmjopen-2019-033322.

引用本文的文献

1
Health Statuses of People in Poverty Receiving Public Assistance in Japan: A Scoping Review.日本接受公共援助的贫困人口的健康状况:一项范围综述。
JMA J. 2024 Jul 16;7(3):301-312. doi: 10.31662/jmaj.2024-0062. Epub 2024 Jun 28.
2
Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan.利用日本全国数据库研究肺癌治疗中表皮生长因子受体酪氨酸激酶抑制剂治疗的地域差异。
Sci Rep. 2023 Mar 30;13(1):5208. doi: 10.1038/s41598-023-31856-6.

本文引用的文献

1
Regional Inequality in Dental Care Utilization in Japan: An Ecological Study Using the National Database of Health Insurance Claims.日本牙科保健利用的地区不平等:一项使用全国健康保险索赔数据库的生态研究
Lancet Reg Health West Pac. 2021 Jun 14;12:100170. doi: 10.1016/j.lanwpc.2021.100170. eCollection 2021 Jul.
2
Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.2009 年至 2016 年美国医生办公室就诊的老年患者多药治疗的流行情况。
PLoS One. 2021 Aug 3;16(8):e0255642. doi: 10.1371/journal.pone.0255642. eCollection 2021.
3
Geographic variations in rheumatoid arthritis treatment in Japan: A nationwide retrospective study using the national database of health insurance claims and specific health checkups of Japan.日本类风湿关节炎治疗的地域差异:一项利用日本国民健康保险索赔和特定健康检查国家数据库的全国回顾性研究。
Mod Rheumatol. 2022 Jan 5;32(1):105-113. doi: 10.1080/14397595.2021.1910615.
4
The Significant Association between Health Examination Results and Population Health: A Cross-Sectional Ecological Study Using a Nation-Wide Health Checkup Database in Japan.健康检查结果与人群健康的显著关联:一项使用日本全国健康检查数据库的横断面生态学研究。
Int J Environ Res Public Health. 2021 Jan 19;18(2):836. doi: 10.3390/ijerph18020836.
5
Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice.老年人的多重疾病与多重用药:临床实践面临的挑战与机遇
Geriatrics (Basel). 2020 Oct 28;5(4):85. doi: 10.3390/geriatrics5040085.
6
Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study.65 岁以上人群的多种合并症模式、多种药物治疗及其与肝肾功能异常的关系:一项纵向研究。
BMC Geriatr. 2020 Jun 12;20(1):206. doi: 10.1186/s12877-020-01580-1.
7
Higher Participation Rate for Specific Health Checkups Concerning Simultaneous Ophthalmic Checkups.特定健康检查中同时进行眼科检查的参与率较高。
J Epidemiol. 2021 May 5;31(5):315-319. doi: 10.2188/jea.JE20200052. Epub 2020 Oct 17.
8
Implications of multimorbidity on healthcare utilisation and work productivity by socioeconomic groups: Cross-sectional analyses of Australia and Japan.多病症对澳大利亚和日本不同社会经济群体的医疗保健利用和工作生产力的影响:横断面分析。
PLoS One. 2020 Apr 28;15(4):e0232281. doi: 10.1371/journal.pone.0232281. eCollection 2020.
9
Association between socioeconomic status and the development of mental and physical health conditions in adulthood: a multi-cohort study.社会经济地位与成年期身心健康状况发展的关联:一项多队列研究。
Lancet Public Health. 2020 Mar;5(3):e140-e149. doi: 10.1016/S2468-2667(19)30248-8. Epub 2020 Jan 31.
10
Polypharmacy in elderly patients in Japan: Analysis of Japanese real-world databases.日本老年患者的多种药物治疗:日本真实世界数据库分析。
J Clin Pharm Ther. 2020 Oct;45(5):991-996. doi: 10.1111/jcpt.13122. Epub 2020 Jan 27.